Abstract
Cerebral radiation necrosis (CRN) is a toxicity of radiation therapy that can result in significant, potentially life-threatening neurologic deficits. Treatment for CRN has included surgical resection, corticosteroids, hyperbaric oxygen therapy (HBOT), and bevacizumab, but no consensus approach has been identified. We reviewed the available literature to evaluate efficacy of treatment approaches. Using methods specified in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines when possible, we conducted searches of Ovid MEDLINE, Embase and Pubmed to identify studies reporting on outcomes for children (≤21 years old) with CRN. Eligible studies from 1990 to 2014 describing central nervous system (CNS) radiation necrosis with details of both treatment and outcomes were included. Eleven studies meeting criteria were identified. Of the nine studies with total patient denominators, 37 of 806 patients developed CRN (incidence = 4.6 %). Patients received treatment courses of steroids alone (n = 13), steroids with bevacizumab (n = 11) or HBOT (n = 12). Patients who failed to respond to steroids were more likely to be older than steroid-responsive patients (p = 0.009). With the exception of steroid-related adverse events, there was only one report of an adverse event (brainstem stroke) potentially attributable to intervention (bevacizumab). Those who received proton beam RT were both younger (p = 0.001) and had a shorter time to development of CRN (p = 0.079). The most common treatment following steroid initiation was addition of bevacizumab or HBOT, with good success and minimal toxicity. However, randomized controlled trials are needed to establish a definitive treatment algorithm that can be applied to children affected by CRN.
Similar content being viewed by others
References
Smith MA, Seibel NL, Reaman GH et al (2010) Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 28(15):2625–2634
Ostrom QT, Gittelman H, Farah P et al (2013) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. Neurooncol 15:ii1–ii56
Greene-Schloesser D, Robbins ME, Peiffer AM et al (2012) Radiation-induced brain injury: a review. Front Oncol 2(73):1–18
Rogers LR, Gutierrez J, Scarpace L et al (2011) Morphologic magnetic resonance imaging features of therapy-induced cerebral necrosis. J Neurooncol 101:25–32
Lawrence YR, Li XA, el Naqa I et al (2010) Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 76(3 suppl):20–27
Hodgson DC, Goumnerova LC, Loeffler JS et al (2001) Radiosurgery in the management of pediatric brain tumors. Int J Radiat Oncol Biol Phys 50(4):929–935
Kalapurakal JA, Kepka A, Bista T et al (2000) Fractionated stereotactic radiotherapy for pediatric brain tumors: the Chicago children’s experience. Child’s Nerv Syst 16:296–303
Plimpton SR, Stence N, Hemenway M, Hankinson TC, Foreman N, Liu AK (2015) Cerebral radiation necrosis in pediatric patients. Pediatri Hematol Oncol 32(1):78–83
Mohler D, Shamseer L, Clarke M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 Statement. Syst Rev 4:1
Indelicato DJ, Flampouri S, Rotondo RL et al (2014) Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy. Acta Oncol 53:1298–1304
Marks JE, Baglan RJ, Prassad SC, Blank WF (1981) Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume. Int J Radiat Oncol Biol Phys 7(2):243–252
Chuba PJ, Aronin P, Bhambhani K et al (1997) Hyperbaric oxygen therapy for radiation-induced brain injury in children. Cancer 80(10):2005–2012
Beuthien-Baumann B, Hahn G, Winkler C, Heubner G (2003) Differentiation between recurrent tumor and radiation necrosis in a child with anaplastic ependymoma after chemotherapy and radiation therapy. Strahlenther Oncol 12:819–822
Liu AK, Macy ME, Foreman NK (2009) Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas. Int J Radiat Oncol Biol Phys 75(4):1148–1154
Murphy ES, Merchant TE, Wu S et al (2012) Necrosis after craniospinal irradiation: results from a prospective series of children with central nervous system embryonal tumors. Int J Radiat Oncol Biol Phys 83(5):e655–e660
Wang Y, Pan L, Sheng X et al (2012) Reversal of cerebral radiation necrosis with bevacizumab in 17 Chinese patients. Eur J Med Res 17:25
Strenger V, Lackner H, Mayer R (2013) Incidence and clinical course of radionecrosis in children with brain tumors. Strahlenther Oncol 189:759–764
Foster KA, Ares WJ, Pollack IF, Jakacki RI (2014) Bevacizumab for symptomatic radiation-induced tumor enlargement in pediatric low grade gliomas. Pediatr Blood Cancer. doi:10.1002/pbc.25277
Preuss M, Hirsch W, Hoffmann KT, Bernhard MK, Siekmeyer M, Kiess W, Meixensberger J, Wurm RE, Merkenschlager A (2013) Effectiveness of bevacizumab for radiation-induced cerebral necrosis in children. Pediatr Neurosurg 49(2):81–85
Furuse M, Kawabata S, Kuroiwa T, Miyatake SI (2011) Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases. J Neuro-Oncol 102(3):471–475
Byrd SE, Tomita T, Palka PS, Darling CF, Norfray JP, Fan J (1996) Magnetic resonance spectroscopy (MRS) in the evaluation of pediatric brain tumors part II: clinical analysis. J Natl Med Assoc 88(11):717–723
Kumar AJ, Leeds NE, Fuller GN et al (2000) Malignant gliomas: MR imaging spectrum of radiation therapy and chemotherapy-induced necrosis of the brain after treatment. Radiology 217:377–384
Stockham AL, Ahluwalia M, Reddy CA et al (2013) Results of a questionnaire regarding practice patterns for the diagnosis and treatment of intracranial radiation necrosis after SRS. J Neurooncol 115:469–475
Sadraei NH, Dahiya S, Chao ST et al (2013) Treatment of cerebral radiation necrosis with bevacizumab: the cleveland clinic experience. Am J Clin Oncol 00:1–7
Ruben JD, Dally M, Bailey M et al (2006) Cerebral Radiation Necrosis: Incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy. Int J Radiat Oncol Biol Phys 65(2):499–508
Kuffler DP (2012) Hyperbaric oxygen therapy: Can it prevent irradiation-induced necrosis? Exp Neurol 235:517–527
Alessandretti M, Buzaid AC, Brandao R, Brandao E (2013) Low-dose bevacizumab is effective in radiation-induced necrosis. Case Rep Oncol 6:598–601
Happold C, Ernemann U, Roth P et al (2008) Anticoagulation for radiation-induced neurotoxicity revisited. J Neurooncol 90:357–361
Glantz MJ, Burger PC, Friedman AH et al (1994) Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology 44(11):2020–2027
Williamson R, Kondziolka D, Kanaan H et al (2008) Adverse radiation effects after radiosurgery may benefit from oral vitamin e and pentoxifylline therapy: a pilot study. Stereotact Funct Neurosurg 86:359–366
Wanebo JE, Kidd GA, King MC, Chung TS (2009) Hyperbaric oxygen therapy for treatment of adverse radiation effects after stereotactic radiosurgery of arteriovenous malformations: case report and review of literature. Surg Neurol 72:162–168
Helton KJ, Edwards M, Steen G et al (2005) Neuroimaging-detected late transient treatment-induced lesions in pediatric patients with brain tumors. J Neurosurg 102:179–186
Sundgren PC, Cao Y (2009) Brain irradiation: effects on normal brain parenchyma and radiation injury. Neuroimag Clin N Am 19:657–668
Acknowledgments
This project wishes to acknowledge the support of the Tucker Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest to disclose for this project.
Rights and permissions
About this article
Cite this article
Drezner, N., Hardy, K.K., Wells, E. et al. Treatment of pediatric cerebral radiation necrosis: a systematic review. J Neurooncol 130, 141–148 (2016). https://doi.org/10.1007/s11060-016-2219-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-016-2219-5